234 related articles for article (PubMed ID: 29861387)
1. Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis.
Winter C; Silvestre-Roig C; Ortega-Gomez A; Lemnitzer P; Poelman H; Schumski A; Winter J; Drechsler M; de Jong R; Immler R; Sperandio M; Hristov M; Zeller T; Nicolaes GAF; Weber C; Viola JR; Hidalgo A; Scheiermann C; Soehnlein O
Cell Metab; 2018 Jul; 28(1):175-182.e5. PubMed ID: 29861387
[TBL] [Abstract][Full Text] [Related]
2. Gas6 Promotes Inflammatory (CCR2
Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
[TBL] [Abstract][Full Text] [Related]
3. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
4. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
5. Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment.
Drechsler M; de Jong R; Rossaint J; Viola JR; Leoni G; Wang JM; Grommes J; Hinkel R; Kupatt C; Weber C; Döring Y; Zarbock A; Soehnlein O
Circ Res; 2015 Feb; 116(5):827-35. PubMed ID: 25520364
[TBL] [Abstract][Full Text] [Related]
6. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
Chen H; Yang J; Zhang Q; Chen LH; Wang Q
Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
[TBL] [Abstract][Full Text] [Related]
7. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
8. CCL2-CCR2 signaling promotes hepatic ischemia/reperfusion injury.
Zhang J; Xu P; Song P; Wang H; Zhang Y; Hu Q; Wang G; Zhang S; Yu Q; Billiar TR; Wang C; Zhang J
J Surg Res; 2016 May; 202(2):352-62. PubMed ID: 27229110
[TBL] [Abstract][Full Text] [Related]
9. Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis.
Yuanyuan L; Yakun L; Zhongyao L; Le Y; Weisong D; Moran G; Hui B; Chunyan L
Exp Cell Res; 2021 Feb; 399(2):112467. PubMed ID: 33428904
[TBL] [Abstract][Full Text] [Related]
10. Ly6C
Schloss MJ; Hilby M; Nitz K; Guillamat Prats R; Ferraro B; Leoni G; Soehnlein O; Kessler T; He W; Luckow B; Horckmans M; Weber C; Duchene J; Steffens S
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1640-1645. PubMed ID: 28663258
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Targeting of the CCL2/CCR2 Axis for Atheroprotection: A Meta-Analysis of Preclinical Studies.
Živković L; Asare Y; Bernhagen J; Dichgans M; Georgakis MK
Arterioscler Thromb Vasc Biol; 2022 May; 42(5):e131-e144. PubMed ID: 35387476
[TBL] [Abstract][Full Text] [Related]
12. Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling.
Yamazaki S; Mabuchi Y; Kimura T; Suto EG; Hisamatsu D; Naraoka Y; Kondo A; Azuma Y; Kikuchi R; Nishikii H; Morishita S; Araki M; Komatsu N; Akazawa C
Stem Cell Reports; 2024 Mar; 19(3):414-425. PubMed ID: 38428413
[TBL] [Abstract][Full Text] [Related]
13. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
[TBL] [Abstract][Full Text] [Related]
14. Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications.
Zhang H; Yang K; Chen F; Liu Q; Ni J; Cao W; Hua Y; He F; Liu Z; Li L; Fan G
Front Immunol; 2022; 13():975367. PubMed ID: 36110847
[TBL] [Abstract][Full Text] [Related]
15. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
16. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
[TBL] [Abstract][Full Text] [Related]
17. β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury.
Grisanti LA; Traynham CJ; Repas AA; Gao E; Koch WJ; Tilley DG
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15126-15131. PubMed ID: 27956622
[TBL] [Abstract][Full Text] [Related]
18. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
19. The regulation and importance of monocyte chemoattractant protein-1.
Bianconi V; Sahebkar A; Atkin SL; Pirro M
Curr Opin Hematol; 2018 Jan; 25(1):44-51. PubMed ID: 28914666
[TBL] [Abstract][Full Text] [Related]
20. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
